Maslova N F, Bomko T V
Eksp Klin Farmakol. 1995 Jan-Feb;58(1):35-7.
A model of experimental pancreatitis was used to study the enzymatic compensatory properties of a new polyenzymatic complex. When given in a dose of 70 mg/kg, the complex was found to normalize amylolytic, lipolytic and partially proteolytic activities in the small intestinal cavity of rats. The complex had some advantages in exhibiting its pharmacological effect over some foreign drugs.
采用实验性胰腺炎模型研究一种新型多酶复合物的酶补偿特性。当以70mg/kg的剂量给药时,发现该复合物可使大鼠小肠腔内的淀粉酶活性、脂肪酶活性及部分蛋白酶活性恢复正常。与一些国外药物相比,该复合物在发挥药理作用方面具有一些优势。